Marquette Asset Management, LLC

Source: SEC Form 13F · as of Mar 2026

Marquette Asset Management, LLC holds 49 biotech & pharma companies tracked by BioSniper, totaling $1.4M in value as of Mar 2026 (SEC Form 13F).

Companies held

49

Total value held

$1.4M

CompanySharesValue
UTHRUNITED THERAPEUTICS Corp1,010$599K
JNJJOHNSON & JOHNSON962$235K
AMGNAMGEN INC278$98K
LLYELI LILLY & Co83$76K
PMPhilip Morris International Inc366$61K
MRKMerck & Co., Inc.370$45K
ABTABBOTT LABORATORIES384$39K
MCKMcKesson Corporation44$38K
GILDGILEAD SCIENCES, INC.225$31K
PFEPFIZER INC862$24K
ABBVAbbVie Inc.92$20K
VRTXVERTEX PHARMACEUTICALS INC / MA42$19K
CAHCardinal Health Inc.67$14K
GMOptec International, Inc.164$12K
BMYBRISTOL MYERS SQUIBB CO189$11K
REGNREGENERON PHARMACEUTICALS, INC.14$11K
ROIVRoivant Sciences Ltd.284$8K
GMEDGlobus Medical Inc.72$6K
BIIBBIOGEN INC.30$6K
CORCencora Inc.17$5K
NBIXNEUROCRINE BIOSCIENCES INC31$4K
INCYIncyte Corp.42$4K
NUVLNuvalent, Inc.32$3K
PTGXProtagonist Therapeutics, Inc28$3K
ZBHZimmer Biomet Holdings Inc.32$3K
IDXXIDEXX LABORATORIES INC /DE5$3K
NVSNovartis AG17$3K
CPRXCATALYST PHARMACEUTICALS, INC.83$2K
BBIOBridgeBio Pharma, Inc.27$2K
ALNYALNYLAM PHARMACEUTICALS, INC.6$2K
RVMDREVOLUTION MEDICINES, INC.20$2K
PTCTPTC THERAPEUTICS, INC.26$2K
IQVIQVIA Holdings Inc.10$2K
TGTXTG THERAPEUTICS, INC.49$2K
ACADACADIA PHARMACEUTICALS INC71$2K
ARWRARROWHEAD PHARMACEUTICALS, INC.25$2K
MRNAModerna, Inc.30$2K
ALKSAlkermes plc.36$1K
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.7$1K
DGXQuest Diagnostics Incorporated6$1K
SMMTSummit Therapeutics Inc.44$835
MMSIMerit Medical Systems Inc.12$828
ELANElanco Animal Health Inc33$790
RIOTRiot Platforms, Inc.57$705
AXSMAxsome Therapeutics, Inc.4$677
KYMRKymera Therapeutics, Inc.6$500
ADMAADMA BIOLOGICS, INC.55$496
CLOVClover Health Investments Corp.239$421
VTRSViatris Inc3$41

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Marquette Asset Management, LLC — Biotech 13F Holdings & Portfolio | BioSniper